Global Oncology/Anti-Cancer Drugs Market Research Report 2017

October 2017 | 107 pages | ID: GD4221C59A3PEN
QYResearch

Abstracts

In this report, the global Oncology/Anti-Cancer Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Oncology/Anti-Cancer Drugs in these regions, from 2012 to 2022 (forecast), covering

• North America
• Europe
• China
• Japan
• Southeast Asia
• India

Global Oncology/Anti-Cancer Drugs market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including

• Amgen
• AstraZeneca
• Roche Diagnostics
• GlaxoSmithKline
• Merck
• Novartis
• AbbVie
• Sanofi
• EIMC United Pharmaceuticals
• Actavis

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Chemotherapy
• Targeted Therapy
• Immunotherapy (Biologic Therapy)
• Hormonal Therapy
• Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Oncology/Anti-Cancer Drugs for each application, including

• Blood Cancer (Leukaemia)
• Breast Cancer
• Gastrointestinal Cancer
• Respiratory/Lung Cancer
• Skin Cancer
• Other Cancers

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Global Oncology/Anti-Cancer Drugs Market Research Report 2017

1 ONCOLOGY/ANTI-CANCER DRUGS MARKET OVERVIEW

1.1 Product Overview and Scope of Oncology/Anti-Cancer Drugs
1.2 Oncology/Anti-Cancer Drugs Segment by Type (Product Category)
  1.2.1 Global Oncology/Anti-Cancer Drugs Production and CAGR (%) Comparison by Type (Product Category)(2012-2022)
  1.2.2 Global Oncology/Anti-Cancer Drugs Production Market Share by Type (Product Category) in 2016
  1.2.3 Chemotherapy
  1.2.4 Targeted Therapy
  1.2.5 Immunotherapy (Biologic Therapy)
  1.2.6 Hormonal Therapy
  1.2.7 Others
1.3 Global Oncology/Anti-Cancer Drugs Segment by Application
  1.3.1 Oncology/Anti-Cancer Drugs Consumption (Sales) Comparison by Application (2012-2022)
  1.3.2 Blood Cancer (Leukaemia)
  1.3.3 Breast Cancer
  1.3.4 Gastrointestinal Cancer
  1.3.5 Respiratory/Lung Cancer
  1.3.6 Skin Cancer
  1.3.7 Other Cancers
1.4 Global Oncology/Anti-Cancer Drugs Market by Region (2012-2022)
  1.4.1 Global Oncology/Anti-Cancer Drugs Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
  1.4.2 North America Status and Prospect (2012-2022)
  1.4.3 Europe Status and Prospect (2012-2022)
  1.4.4 China Status and Prospect (2012-2022)
  1.4.5 Japan Status and Prospect (2012-2022)
  1.4.6 Southeast Asia Status and Prospect (2012-2022)
  1.4.7 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value) of Oncology/Anti-Cancer Drugs (2012-2022)
  1.5.1 Global Oncology/Anti-Cancer Drugs Revenue Status and Outlook (2012-2022)
  1.5.2 Global Oncology/Anti-Cancer Drugs Capacity, Production Status and Outlook (2012-2022)

2 GLOBAL ONCOLOGY/ANTI-CANCER DRUGS MARKET COMPETITION BY MANUFACTURERS

2.1 Global Oncology/Anti-Cancer Drugs Capacity, Production and Share by Manufacturers (2012-2017)
  2.1.1 Global Oncology/Anti-Cancer Drugs Capacity and Share by Manufacturers (2012-2017)
  2.1.2 Global Oncology/Anti-Cancer Drugs Production and Share by Manufacturers (2012-2017)
2.2 Global Oncology/Anti-Cancer Drugs Revenue and Share by Manufacturers (2012-2017)
2.3 Global Oncology/Anti-Cancer Drugs Average Price by Manufacturers (2012-2017)
2.4 Manufacturers Oncology/Anti-Cancer Drugs Manufacturing Base Distribution, Sales Area and Product Type
2.5 Oncology/Anti-Cancer Drugs Market Competitive Situation and Trends
  2.5.1 Oncology/Anti-Cancer Drugs Market Concentration Rate
  2.5.2 Oncology/Anti-Cancer Drugs Market Share of Top 3 and Top 5 Manufacturers
  2.5.3 Mergers & Acquisitions, Expansion

3 GLOBAL ONCOLOGY/ANTI-CANCER DRUGS CAPACITY, PRODUCTION, REVENUE (VALUE) BY REGION (2012-2017)

3.1 Global Oncology/Anti-Cancer Drugs Capacity and Market Share by Region (2012-2017)
3.2 Global Oncology/Anti-Cancer Drugs Production and Market Share by Region (2012-2017)
3.3 Global Oncology/Anti-Cancer Drugs Revenue (Value) and Market Share by Region (2012-2017)
3.4 Global Oncology/Anti-Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.5 North America Oncology/Anti-Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.6 Europe Oncology/Anti-Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.7 China Oncology/Anti-Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.8 Japan Oncology/Anti-Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.9 Southeast Asia Oncology/Anti-Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.10 India Oncology/Anti-Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 GLOBAL ONCOLOGY/ANTI-CANCER DRUGS SUPPLY (PRODUCTION), CONSUMPTION, EXPORT, IMPORT BY REGION (2012-2017)

4.1 Global Oncology/Anti-Cancer Drugs Consumption by Region (2012-2017)
4.2 North America Oncology/Anti-Cancer Drugs Production, Consumption, Export, Import (2012-2017)
4.3 Europe Oncology/Anti-Cancer Drugs Production, Consumption, Export, Import (2012-2017)
4.4 China Oncology/Anti-Cancer Drugs Production, Consumption, Export, Import (2012-2017)
4.5 Japan Oncology/Anti-Cancer Drugs Production, Consumption, Export, Import (2012-2017)
4.6 Southeast Asia Oncology/Anti-Cancer Drugs Production, Consumption, Export, Import (2012-2017)
4.7 India Oncology/Anti-Cancer Drugs Production, Consumption, Export, Import (2012-2017)

5 GLOBAL ONCOLOGY/ANTI-CANCER DRUGS PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 Global Oncology/Anti-Cancer Drugs Production and Market Share by Type (2012-2017)
5.2 Global Oncology/Anti-Cancer Drugs Revenue and Market Share by Type (2012-2017)
5.3 Global Oncology/Anti-Cancer Drugs Price by Type (2012-2017)
5.4 Global Oncology/Anti-Cancer Drugs Production Growth by Type (2012-2017)

6 GLOBAL ONCOLOGY/ANTI-CANCER DRUGS MARKET ANALYSIS BY APPLICATION

6.1 Global Oncology/Anti-Cancer Drugs Consumption and Market Share by Application (2012-2017)
6.2 Global Oncology/Anti-Cancer Drugs Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Applications
  6.3.2 Emerging Markets/Countries

7 GLOBAL ONCOLOGY/ANTI-CANCER DRUGS MANUFACTURERS PROFILES/ANALYSIS

7.1 Amgen
  7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.1.2 Oncology/Anti-Cancer Drugs Product Category, Application and Specification
    7.1.2.1 Product A
    7.1.2.2 Product B
  7.1.3 Amgen Oncology/Anti-Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.1.4 Main Business/Business Overview
7.2 AstraZeneca
  7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.2.2 Oncology/Anti-Cancer Drugs Product Category, Application and Specification
    7.2.2.1 Product A
    7.2.2.2 Product B
  7.2.3 AstraZeneca Oncology/Anti-Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.2.4 Main Business/Business Overview
7.3 Roche Diagnostics
  7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.3.2 Oncology/Anti-Cancer Drugs Product Category, Application and Specification
    7.3.2.1 Product A
    7.3.2.2 Product B
  7.3.3 Roche Diagnostics Oncology/Anti-Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.3.4 Main Business/Business Overview
7.4 GlaxoSmithKline
  7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.4.2 Oncology/Anti-Cancer Drugs Product Category, Application and Specification
    7.4.2.1 Product A
    7.4.2.2 Product B
  7.4.3 GlaxoSmithKline Oncology/Anti-Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.4.4 Main Business/Business Overview
7.5 Merck
  7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.5.2 Oncology/Anti-Cancer Drugs Product Category, Application and Specification
    7.5.2.1 Product A
    7.5.2.2 Product B
  7.5.3 Merck Oncology/Anti-Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.5.4 Main Business/Business Overview
7.6 Novartis
  7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.6.2 Oncology/Anti-Cancer Drugs Product Category, Application and Specification
    7.6.2.1 Product A
    7.6.2.2 Product B
  7.6.3 Novartis Oncology/Anti-Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.6.4 Main Business/Business Overview
7.7 AbbVie
  7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.7.2 Oncology/Anti-Cancer Drugs Product Category, Application and Specification
    7.7.2.1 Product A
    7.7.2.2 Product B
  7.7.3 AbbVie Oncology/Anti-Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.7.4 Main Business/Business Overview
7.8 Sanofi
  7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.8.2 Oncology/Anti-Cancer Drugs Product Category, Application and Specification
    7.8.2.1 Product A
    7.8.2.2 Product B
  7.8.3 Sanofi Oncology/Anti-Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.8.4 Main Business/Business Overview
7.9 EIMC United Pharmaceuticals
  7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.9.2 Oncology/Anti-Cancer Drugs Product Category, Application and Specification
    7.9.2.1 Product A
    7.9.2.2 Product B
  7.9.3 EIMC United Pharmaceuticals Oncology/Anti-Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.9.4 Main Business/Business Overview
7.10 Actavis
  7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.10.2 Oncology/Anti-Cancer Drugs Product Category, Application and Specification
    7.10.2.1 Product A
    7.10.2.2 Product B
  7.10.3 Actavis Oncology/Anti-Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.10.4 Main Business/Business Overview

8 ONCOLOGY/ANTI-CANCER DRUGS MANUFACTURING COST ANALYSIS

8.1 Oncology/Anti-Cancer Drugs Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Oncology/Anti-Cancer Drugs

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Oncology/Anti-Cancer Drugs Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Oncology/Anti-Cancer Drugs Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL ONCOLOGY/ANTI-CANCER DRUGS MARKET FORECAST (2017-2022)

12.1 Global Oncology/Anti-Cancer Drugs Capacity, Production, Revenue Forecast (2017-2022)
  12.1.1 Global Oncology/Anti-Cancer Drugs Capacity, Production and Growth Rate Forecast (2017-2022)
  12.1.2 Global Oncology/Anti-Cancer Drugs Revenue and Growth Rate Forecast (2017-2022)
  12.1.3 Global Oncology/Anti-Cancer Drugs Price and Trend Forecast (2017-2022)
12.2 Global Oncology/Anti-Cancer Drugs Production, Consumption, Import and Export Forecast by Region (2017-2022)
  12.2.1 North America Oncology/Anti-Cancer Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.2 Europe Oncology/Anti-Cancer Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.3 China Oncology/Anti-Cancer Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.4 Japan Oncology/Anti-Cancer Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.5 Southeast Asia Oncology/Anti-Cancer Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.6 India Oncology/Anti-Cancer Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.3 Global Oncology/Anti-Cancer Drugs Production, Revenue and Price Forecast by Type (2017-2022)
12.4 Global Oncology/Anti-Cancer Drugs Consumption Forecast by Application (2017-2022)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology/Research Approach
  14.1.1 Research Programs/Design
  14.1.2 Market Size Estimation
  14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
  14.2.1 Secondary Sources
  14.2.2 Primary Sources
14.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Oncology/Anti-Cancer Drugs
Figure Global Oncology/Anti-Cancer Drugs Production (K Units) and CAGR (%) Comparison by Types (Product Category) (2012-2022)
Figure Global Oncology/Anti-Cancer Drugs Production Market Share by Types (Product Category) in 2016
Figure Product Picture of Chemotherapy
Table Major Manufacturers of Chemotherapy
Figure Product Picture of Targeted Therapy
Table Major Manufacturers of Targeted Therapy
Figure Product Picture of Immunotherapy (Biologic Therapy)
Table Major Manufacturers of Immunotherapy (Biologic Therapy)
Figure Product Picture of Hormonal Therapy
Table Major Manufacturers of Hormonal Therapy
Figure Product Picture of Others
Table Major Manufacturers of Others
Figure Global Oncology/Anti-Cancer Drugs Consumption (K Units) by Applications (2012-2022)
Figure Global Oncology/Anti-Cancer Drugs Consumption Market Share by Applications in 2016
Figure Blood Cancer (Leukaemia) Examples
Table Key Downstream Customer in Blood Cancer (Leukaemia)
Figure Breast Cancer Examples
Table Key Downstream Customer in Breast Cancer
Figure Gastrointestinal Cancer Examples
Table Key Downstream Customer in Gastrointestinal Cancer
Figure Respiratory/Lung Cancer Examples
Table Key Downstream Customer in Respiratory/Lung Cancer
Figure Skin Cancer Examples
Table Key Downstream Customer in Skin Cancer
Figure Other Cancers Examples
Table Key Downstream Customer in Other Cancers
Figure Global Oncology/Anti-Cancer Drugs Market Size (Million USD), Comparison (K Units) and CAGR (%) by Regions (2012-2022)
Figure North America Oncology/Anti-Cancer Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Oncology/Anti-Cancer Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Oncology/Anti-Cancer Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Oncology/Anti-Cancer Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Oncology/Anti-Cancer Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Oncology/Anti-Cancer Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Oncology/Anti-Cancer Drugs Revenue (Million USD) Status and Outlook (2012-2022)
Figure Global Oncology/Anti-Cancer Drugs Capacity, Production (K Units) Status and Outlook (2012-2022)
Figure Global Oncology/Anti-Cancer Drugs Major Players Product Capacity (K Units) (2012-2017)
Table Global Oncology/Anti-Cancer Drugs Capacity (K Units) of Key Manufacturers (2012-2017)
Table Global Oncology/Anti-Cancer Drugs Capacity Market Share of Key Manufacturers (2012-2017)
Figure Global Oncology/Anti-Cancer Drugs Capacity (K Units) of Key Manufacturers in 2016
Figure Global Oncology/Anti-Cancer Drugs Capacity (K Units) of Key Manufacturers in 2017
Figure Global Oncology/Anti-Cancer Drugs Major Players Product Production (K Units) (2012-2017)
Table Global Oncology/Anti-Cancer Drugs Production (K Units) of Key Manufacturers (2012-2017)
Table Global Oncology/Anti-Cancer Drugs Production Share by Manufacturers (2012-2017)
Figure 2016 Oncology/Anti-Cancer Drugs Production Share by Manufacturers
Figure 2017 Oncology/Anti-Cancer Drugs Production Share by Manufacturers
Figure Global Oncology/Anti-Cancer Drugs Major Players Product Revenue (Million USD) (2012-2017)
Table Global Oncology/Anti-Cancer Drugs Revenue (Million USD) by Manufacturers (2012-2017)
Table Global Oncology/Anti-Cancer Drugs Revenue Share by Manufacturers (2012-2017)
Table 2016 Global Oncology/Anti-Cancer Drugs Revenue Share by Manufacturers
Table 2017 Global Oncology/Anti-Cancer Drugs Revenue Share by Manufacturers
Table Global Market Oncology/Anti-Cancer Drugs Average Price (USD/Unit) of Key Manufacturers (2012-2017)
Figure Global Market Oncology/Anti-Cancer Drugs Average Price (USD/Unit) of Key Manufacturers in 2016
Table Manufacturers Oncology/Anti-Cancer Drugs Manufacturing Base Distribution and Sales Area
Table Manufacturers Oncology/Anti-Cancer Drugs Product Category
Figure Oncology/Anti-Cancer Drugs Market Share of Top 3 Manufacturers
Figure Oncology/Anti-Cancer Drugs Market Share of Top 5 Manufacturers
Table Global Oncology/Anti-Cancer Drugs Capacity (K Units) by Region (2012-2017)
Figure Global Oncology/Anti-Cancer Drugs Capacity Market Share by Region (2012-2017)
Figure Global Oncology/Anti-Cancer Drugs Capacity Market Share by Region (2012-2017)
Figure 2016 Global Oncology/Anti-Cancer Drugs Capacity Market Share by Region
Table Global Oncology/Anti-Cancer Drugs Production by Region (2012-2017)
Figure Global Oncology/Anti-Cancer Drugs Production (K Units) by Region (2012-2017)
Figure Global Oncology/Anti-Cancer Drugs Production Market Share by Region (2012-2017)
Figure 2016 Global Oncology/Anti-Cancer Drugs Production Market Share by Region
Table Global Oncology/Anti-Cancer Drugs Revenue (Million USD) by Region (2012-2017)
Table Global Oncology/Anti-Cancer Drugs Revenue Market Share by Region (2012-2017)
Figure Global Oncology/Anti-Cancer Drugs Revenue Market Share by Region (2012-2017)
Table 2016 Global Oncology/Anti-Cancer Drugs Revenue Market Share by Region
Figure Global Oncology/Anti-Cancer Drugs Capacity, Production (K Units) and Growth Rate (2012-2017)
Table Global Oncology/Anti-Cancer Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table North America Oncology/Anti-Cancer Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table Europe Oncology/Anti-Cancer Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table China Oncology/Anti-Cancer Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table Japan Oncology/Anti-Cancer Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table Southeast Asia Oncology/Anti-Cancer Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table India Oncology/Anti-Cancer Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table Global Oncology/Anti-Cancer Drugs Consumption (K Units) Market by Region (2012-2017)
Table Global Oncology/Anti-Cancer Drugs Consumption Market Share by Region (2012-2017)
Figure Global Oncology/Anti-Cancer Drugs Consumption Market Share by Region (2012-2017)
Figure 2016 Global Oncology/Anti-Cancer Drugs Consumption (K Units) Market Share by Region
Table North America Oncology/Anti-Cancer Drugs Production, Consumption, Import & Export (K Units) (2012-2017)
Table Europe Oncology/Anti-Cancer Drugs Production, Consumption, Import & Export (K Units) (2012-2017)
Table China Oncology/Anti-Cancer Drugs Production, Consumption, Import & Export (K Units) (2012-2017)
Table Japan Oncology/Anti-Cancer Drugs Production, Consumption, Import & Export (K Units) (2012-2017)
Table Southeast Asia Oncology/Anti-Cancer Drugs Production, Consumption, Import & Export (K Units) (2012-2017)
Table India Oncology/Anti-Cancer Drugs Production, Consumption, Import & Export (K Units) (2012-2017)
Table Global Oncology/Anti-Cancer Drugs Production (K Units) by Type (2012-2017)
Table Global Oncology/Anti-Cancer Drugs Production Share by Type (2012-2017)
Figure Production Market Share of Oncology/Anti-Cancer Drugs by Type (2012-2017)
Figure 2016 Production Market Share of Oncology/Anti-Cancer Drugs by Type
Table Global Oncology/Anti-Cancer Drugs Revenue (Million USD) by Type (2012-2017)
Table Global Oncology/Anti-Cancer Drugs Revenue Share by Type (2012-2017)
Figure Production Revenue Share of Oncology/Anti-Cancer Drugs by Type (2012-2017)
Figure 2016 Revenue Market Share of Oncology/Anti-Cancer Drugs by Type
Table Global Oncology/Anti-Cancer Drugs Price (USD/Unit) by Type (2012-2017)
Figure Global Oncology/Anti-Cancer Drugs Production Growth by Type (2012-2017)
Table Global Oncology/Anti-Cancer Drugs Consumption (K Units) by Application (2012-2017)
Table Global Oncology/Anti-Cancer Drugs Consumption Market Share by Application (2012-2017)
Figure Global Oncology/Anti-Cancer Drugs Consumption Market Share by Applications (2012-2017)
Figure Global Oncology/Anti-Cancer Drugs Consumption Market Share by Application in 2016
Table Global Oncology/Anti-Cancer Drugs Consumption Growth Rate by Application (2012-2017)
Figure Global Oncology/Anti-Cancer Drugs Consumption Growth Rate by Application (2012-2017)
Table Amgen Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Amgen Oncology/Anti-Cancer Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Amgen Oncology/Anti-Cancer Drugs Production Growth Rate (2012-2017)
Figure Amgen Oncology/Anti-Cancer Drugs Production Market Share (2012-2017)
Figure Amgen Oncology/Anti-Cancer Drugs Revenue Market Share (2012-2017)
Table AstraZeneca Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table AstraZeneca Oncology/Anti-Cancer Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure AstraZeneca Oncology/Anti-Cancer Drugs Production Growth Rate (2012-2017)
Figure AstraZeneca Oncology/Anti-Cancer Drugs Production Market Share (2012-2017)
Figure AstraZeneca Oncology/Anti-Cancer Drugs Revenue Market Share (2012-2017)
Table Roche Diagnostics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Roche Diagnostics Oncology/Anti-Cancer Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Roche Diagnostics Oncology/Anti-Cancer Drugs Production Growth Rate (2012-2017)
Figure Roche Diagnostics Oncology/Anti-Cancer Drugs Production Market Share (2012-2017)
Figure Roche Diagnostics Oncology/Anti-Cancer Drugs Revenue Market Share (2012-2017)
Table GlaxoSmithKline Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GlaxoSmithKline Oncology/Anti-Cancer Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Oncology/Anti-Cancer Drugs Production Growth Rate (2012-2017)
Figure GlaxoSmithKline Oncology/Anti-Cancer Drugs Production Market Share (2012-2017)
Figure GlaxoSmithKline Oncology/Anti-Cancer Drugs Revenue Market Share (2012-2017)
Table Merck Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck Oncology/Anti-Cancer Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Merck Oncology/Anti-Cancer Drugs Production Growth Rate (2012-2017)
Figure Merck Oncology/Anti-Cancer Drugs Production Market Share (2012-2017)
Figure Merck Oncology/Anti-Cancer Drugs Revenue Market Share (2012-2017)
Table Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis Oncology/Anti-Cancer Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Novartis Oncology/Anti-Cancer Drugs Production Growth Rate (2012-2017)
Figure Novartis Oncology/Anti-Cancer Drugs Production Market Share (2012-2017)
Figure Novartis Oncology/Anti-Cancer Drugs Revenue Market Share (2012-2017)
Table AbbVie Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table AbbVie Oncology/Anti-Cancer Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure AbbVie Oncology/Anti-Cancer Drugs Production Growth Rate (2012-2017)
Figure AbbVie Oncology/Anti-Cancer Drugs Production Market Share (2012-2017)
Figure AbbVie Oncology/Anti-Cancer Drugs Revenue Market Share (2012-2017)
Table Sanofi Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sanofi Oncology/Anti-Cancer Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sanofi Oncology/Anti-Cancer Drugs Production Growth Rate (2012-2017)
Figure Sanofi Oncology/Anti-Cancer Drugs Production Market Share (2012-2017)
Figure Sanofi Oncology/Anti-Cancer Drugs Revenue Market Share (2012-2017)
Table EIMC United Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table EIMC United Pharmaceuticals Oncology/Anti-Cancer Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure EIMC United Pharmaceuticals Oncology/Anti-Cancer Drugs Production Growth Rate (2012-2017)
Figure EIMC United Pharmaceuticals Oncology/Anti-Cancer Drugs Production Market Share (2012-2017)
Figure EIMC United Pharmaceuticals Oncology/Anti-Cancer Drugs Revenue Market Share (2012-2017)
Table Actavis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Actavis Oncology/Anti-Cancer Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Actavis Oncology/Anti-Cancer Drugs Production Growth Rate (2012-2017)
Figure Actavis Oncology/Anti-Cancer Drugs Production Market Share (2012-2017)
Figure Actavis Oncology/Anti-Cancer Drugs Revenue Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Oncology/Anti-Cancer Drugs
Figure Manufacturing Process Analysis of Oncology/Anti-Cancer Drugs
Figure Oncology/Anti-Cancer Drugs Industrial Chain Analysis
Table Raw Materials Sources of Oncology/Anti-Cancer Drugs Major Manufacturers in 2016
Table Major Buyers of Oncology/Anti-Cancer Drugs
Table Distributors/Traders List
Figure Global Oncology/Anti-Cancer Drugs Capacity, Production (K Units) and Growth Rate Forecast (2017-2022)
Figure Global Oncology/Anti-Cancer Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Oncology/Anti-Cancer Drugs Price (Million USD) and Trend Forecast (2017-2022)
Table Global Oncology/Anti-Cancer Drugs Production (K Units) Forecast by Region (2017-2022)
Figure Global Oncology/Anti-Cancer Drugs Production Market Share Forecast by Region (2017-2022)
Table Global Oncology/Anti-Cancer Drugs Consumption (K Units) Forecast by Region (2017-2022)
Figure Global Oncology/Anti-Cancer Drugs Consumption Market Share Forecast by Region (2017-2022)
Figure North America Oncology/Anti-Cancer Drugs Production (K Units) and Growth Rate Forecast (2017-2022)
Figure North America Oncology/Anti-Cancer Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table North America Oncology/Anti-Cancer Drugs Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure Europe Oncology/Anti-Cancer Drugs Production (K Units) and Growth Rate Forecast (2017-2022)
Figure Europe Oncology/Anti-Cancer Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Europe Oncology/Anti-Cancer Drugs Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure China Oncology/Anti-Cancer Drugs Production (K Units) and Growth Rate Forecast (2017-2022)
Figure China Oncology/Anti-Cancer Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table China Oncology/Anti-Cancer Drugs Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure Japan Oncology/Anti-Cancer Drugs Production (K Units) and Growth Rate Forecast (2017-2022)
Figure Japan Oncology/Anti-Cancer Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Japan Oncology/Anti-Cancer Drugs Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure Southeast Asia Oncology/Anti-Cancer Drugs Production (K Units) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Oncology/Anti-Cancer Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Southeast Asia Oncology/Anti-Cancer Drugs Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure India Oncology/Anti-Cancer Drugs Production (K Units) and Growth Rate Forecast (2017-2022)
Figure India Oncology/Anti-Cancer Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table India Oncology/Anti-Cancer Drugs Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Table Global Oncology/Anti-Cancer Drugs Production (K Units) Forecast by Type (2017-2022)
Figure Global Oncology/Anti-Cancer Drugs Production (K Units) Forecast by Type (2017-2022)
Table Global Oncology/Anti-Cancer Drugs Revenue (Million USD) Forecast by Type (2017-2022)
Figure Global Oncology/Anti-Cancer Drugs Revenue Market Share Forecast by Type (2017-2022)
Table Global Oncology/Anti-Cancer Drugs Price Forecast by Type (2017-2022)
Table Global Oncology/Anti-Cancer Drugs Consumption (K Units) Forecast by Application (2017-2022)
Figure Global Oncology/Anti-Cancer Drugs Consumption (K Units) Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Source